Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Levodopa
by Highest Patent Value in the Sweden in 2022

The Levodopa top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Levodopa Key Players in the Sweden. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Pharmacopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 4.23 M
2
Avg patent value: 3.24 M
3
Drug discovery,Medicine,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 3.04 M
4
Avg patent value: 613,927
5
Medicine,Health care,Helicobacter pylori,
...[+2]
Avg patent value: 0
Page generation time: May 13 2025